K. Jagarlamudi

发表

Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker

S. Eriksson, H. Rönnberg, K. Jagarlamudi, 2014, BMC Veterinary Research.

A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management

S. Eriksson, H. Rönnberg, K. Jagarlamudi, 2015, PloS one.

Diagnostic implications of the molecular forms and levels of serum thymidine kinase 1 in different canine malignancies

K. Jagarlamudi, 2015 .

Quaternary structures of recombinant, cellular, and serum forms of Thymidine Kinase 1 from dogs and humans

K. Jagarlamudi, Wang Liya, S. Hanan, 2012, BMC Biochemistry.

Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples

K. Jagarlamudi, Z. M., Swinkels L, 2022, PloS one.

The combination of AroCell TK 210 ELISA with Prostate Health Index or prostate‐specific antigen density can improve the ability to differentiate prostate cancer from noncancerous conditions

J. Osredkar, S. Eriksson, K. Kumer, 2019, The Prostate.

J. Osredkar, S. Eriksson, K. Kumer, 2019 .

Doxorubicin effects on leukemia and breast cancer cells in culture on the TK1 protein levels using AroCell TK 210 ELISA: a tool for drug development

S. Eriksson, K. Jagarlamudi, L. Wang, 2018, Nucleosides, nucleotides & nucleic acids.

Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker

L. Hansson, S. Eriksson, K. Jagarlamudi, 2015, BMC Cancer.

Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker.

Martin Shaw, K. Jagarlamudi, 2018, Biomarkers in medicine.

A Dual Biomarker TK1 Protein and CA125 or HE4-Based Algorithm as a Better Diagnostic Tool than ROMA Index in Early Detection of Ovarian Cancer

J. Osredkar, A. Zore, K. Jagarlamudi, 2023, Cancers.

Serum Concentration of Thymidine Kinase 1 (TK1) as a Tumor Marker in Soft Tissue Sarcomas

C. Blomqvist, E. Tukiainen, R. Nevala, 2022, AntiCancer Research.

Serum TK1 protein and C-reactive protein correlate to treatment response and predict survival in dogs with hematologic malignancies.

S. Eriksson, S. Saellström, H. Rönnberg, 2022, Research in veterinary science.

85 - SER-287, an Investigational Microbiome Therapeutic, Induces Remission and Endoscopic Improvement in a Placebo-Controlled, Double-Blind Randomized Trial in Patients with Active Mild-to-Moderate Ulcerative Colitis

M. Henn, R. Pomerantz, H. Herfarth, 2018 .

A monoclonal antibody-based sandwich ELISA for measuring canine Thymidine kinase 1 protein and its role as biomarker in canine lymphoma

Liya Wang, S. Saellström, H. Rönnberg, 2023, Frontiers in veterinary science.